Security Snapshot

NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) Institutional Ownership

CUSIP: 64130M308

13F Institutional Holders and Ownership History from Q1 2026 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

24

Shares (Excl. Options)

2.04MFull value: 2,041,113 · shares · 30 Jun 2026

Price

$3.04

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
NMTC on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
2,041,113
Latest holder snapshot 5 signals
Total 13F value
$6,205,386
Portfolio coverage rank
0%
Share change
+2,041,093
Value change
+$6,205,323
Number of holders
24
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
8,687,472
SEC-reported price per share
$1.02
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock is tracked under CUSIP 64130M308.
  • 24 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 24 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $16 to
    $6.21MFull value: $6,205,386 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 24 institutions filings for Q2 2026.

Open SEC evidence

Security key

64130M308

13F reference period

Q2 2026

13F holders

24

13D/G owners

1

CIK / CUSIP context first

Open Q2 2026 holders NMTC full holder history NEUROONE MEDICAL TECHNOLOGIES Corp SEC filings NEUROONE MEDICAL TECHNOLOGIES Corp company facts NEUROONE MEDICAL TECHNOLOGIES Corp insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
NMTC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Pratt Brian 12% $4,235,143 1,085,934 Brian Pratt 10 Jul 2026
As of 30 Jun 2026, 24 institutional investors reported holding
2.04MFull value: 2,041,113 · shares · 30 Jun 2026
shares of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC). This represents 23% of the company’s total
8.69MFull value: 8,687,472 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 24 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
23%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bleichroeder LP 7.7% 666,666 0.36% $2,026,665
VANGUARD CAPITAL MANAGEMENT LLC 4.1% 352,774 0% $1,072,433
BARD ASSOCIATES INC 3.5% 305,428 0.21% $928,502
PERKINS CAPITAL MANAGEMENT INC 2.8% 244,656 0.56% $743,754
GEODE CAPITAL MANAGEMENT, LLC 1.1% 93,555 0% $284,446
Sio Capital Management, LLC 0.95% 82,767 0.04% $251,612
RENAISSANCE TECHNOLOGIES LLC 0.82% 70,861 0% $215,417
VANGUARD FIDUCIARY TRUST CO 0.56% 49,018 0% $149,015
ESSEX INVESTMENT MANAGEMENT CO LLC 0.5% 43,578 0.02% $132,477
Cambridge Investment Research Advisors, Inc. 0.33% 28,499 0% $87,000
BlackRock, Inc. 0.29% 25,121 0% $76,368
NORTHERN TRUST CORP 0.25% 21,398 0% $65,050
CITADEL ADVISORS LLC 0.17% 15,032 0% $45,697
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.16% 13,520 0% $41,101
Belpointe Asset Management LLC 0.14% 12,500 0% $38,000
Legato Capital Management LLC 0.12% 10,273 0% $31,230
UBS Group AG 0.03% 2,623 0% $7,974
MORGAN STANLEY 0.02% 2,058 0% $6,256
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0% 361 0% $1,097
WELLS FARGO & COMPANY/MN 0% 166 0% $505
Tower Research Capital LLC (TRC) 0% 112 0% $340
BARCLAYS PLC 0% 76 0% $231
OSAIC HOLDINGS, INC. 0% 58 0% $176
SBI Securities Co., Ltd. 0% 13 -35% 0% $40

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
3
Headline period
Q2 2026
Rows shown
1-3 of 3
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 705 $726 -$131,764 $1.02 2
2026 Q2 2,041,113 $6,205,386 +$6,205,323 $3.04 24
2026 Q1 20 $16 +$16 $0.80 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .